Global and China Exanthema Market Size, Status and Forecast 2020-2026
Table of Contents1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Exanthema Market Size Growth Rate by Type: 2020 VS 2026
1.2.2 Rubeola
1.2.3 Rubella
1.2.4 Erythema Infectiosum
1.2.5 Roseola Infantum
1.3 Market by Application
1.3.1 Global Exanthema Market Share by Application: 2020 VS 2026
1.3.2 Hospitals and Clinics
1.3.3 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Exanthema Market Perspective (2015-2026)
2.2 Global Exanthema Growth Trends by Regions
2.2.1 Exanthema Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Exanthema Historic Market Share by Regions (2015-2020)
2.2.3 Exanthema Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Exanthema Players by Market Size
3.1.1 Global Top Exanthema Players by Revenue (2015-2020)
3.1.2 Global Exanthema Revenue Market Share by Players (2015-2020)
3.2 Global Exanthema Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Exanthema Revenue
3.4 Global Exanthema Market Concentration Ratio
3.4.1 Global Exanthema Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Exanthema Revenue in 2019
3.5 Key Players Exanthema Area Served
3.6 Key Players Exanthema Product Solution and Service
3.7 Date of Enter into Exanthema Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Exanthema Breakdown Data by Type (2015-2026)
4.1 Global Exanthema Historic Market Size by Type (2015-2020)
4.2 Global Exanthema Forecasted Market Size by Type (2021-2026)
5 Exanthema Breakdown Data by Application (2015-2026)
5.1 Global Exanthema Historic Market Size by Application (2015-2020)
5.2 Global Exanthema Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Exanthema Market Size (2015-2026)
6.2 North America Exanthema Market Size by Type (2015-2020)
6.3 North America Exanthema Market Size by Application (2015-2020)
6.4 North America Exanthema Market Size by Country (2015-2020)
6.4.1 United States
6.4.2 Canada
7 Europe
7.1 Europe Exanthema Market Size (2015-2026)
7.2 Europe Exanthema Market Size by Type (2015-2020)
7.3 Europe Exanthema Market Size by Application (2015-2020)
7.4 Europe Exanthema Market Size by Country (2015-2020)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
7.4.6 Nordic
7.4.7 Rest of Europe
8 China
8.1 China Exanthema Market Size (2015-2026)
8.2 China Exanthema Market Size by Type (2015-2020)
8.3 China Exanthema Market Size by Application (2015-2020)
8.4 China Exanthema Market Size by Region (2015-2020)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 Southeast Asia
8.4.5 India
8.4.6 Australia
8.4.7 Rest of Asia-Pacific
9 Japan
9.1 Japan Exanthema Market Size (2015-2026)
9.2 Japan Exanthema Market Size by Type (2015-2020)
9.3 Japan Exanthema Market Size by Application (2015-2020)
9.4 Japan Exanthema Market Size by Country (2015-2020)
9.4.1 Mexico
9.4.2 Brazil
10 Southeast Asia
10.1 Southeast Asia Exanthema Market Size (2015-2026)
10.2 Southeast Asia Exanthema Market Size by Type (2015-2020)
10.3 Southeast Asia Exanthema Market Size by Application (2015-2020)
10.4 Southeast Asia Exanthema Market Size by Country (2015-2020)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
10.4.4 Rest of Middle East & Africa
11 Key Players Profiles
11.1 Manus Aktteva Biopharma
11.1.1 Manus Aktteva Biopharma Company Details
11.1.2 Manus Aktteva Biopharma Business Overview
11.1.3 Manus Aktteva Biopharma Exanthema Introduction
11.1.4 Manus Aktteva Biopharma Revenue in Exanthema Business (2015-2020))
11.1.5 Manus Aktteva Biopharma Recent Development
11.2 Teva Pharmaceutical Industries
11.2.1 Teva Pharmaceutical Industries Company Details
11.2.2 Teva Pharmaceutical Industries Business Overview
11.2.3 Teva Pharmaceutical Industries Exanthema Introduction
11.2.4 Teva Pharmaceutical Industries Revenue in Exanthema Business (2015-2020)
11.2.5 Teva Pharmaceutical Industries Recent Development
11.3 CIRON Drugs & Pharmaceuticals
11.3.1 CIRON Drugs & Pharmaceuticals Company Details
11.3.2 CIRON Drugs & Pharmaceuticals Business Overview
11.3.3 CIRON Drugs & Pharmaceuticals Exanthema Introduction
11.3.4 CIRON Drugs & Pharmaceuticals Revenue in Exanthema Business (2015-2020)
11.3.5 CIRON Drugs & Pharmaceuticals Recent Development
11.4 Iol Chemicals and Pharmaceuticals
11.4.1 Iol Chemicals and Pharmaceuticals Company Details
11.4.2 Iol Chemicals and Pharmaceuticals Business Overview
11.4.3 Iol Chemicals and Pharmaceuticals Exanthema Introduction
11.4.4 Iol Chemicals and Pharmaceuticals Revenue in Exanthema Business (2015-2020)
11.4.5 Iol Chemicals and Pharmaceuticals Recent Development
11.5 Mikart
11.5.1 Mikart Company Details
11.5.2 Mikart Business Overview
11.5.3 Mikart Exanthema Introduction
11.5.4 Mikart Revenue in Exanthema Business (2015-2020)
11.5.5 Mikart Recent Development
11.6 Ranbaxy Laboratories
11.6.1 Ranbaxy Laboratories Company Details
11.6.2 Ranbaxy Laboratories Business Overview
11.6.3 Ranbaxy Laboratories Exanthema Introduction
11.6.4 Ranbaxy Laboratories Revenue in Exanthema Business (2015-2020)
11.6.5 Ranbaxy Laboratories Recent Development
11.7 Hikma
11.7.1 Hikma Company Details
11.7.2 Hikma Business Overview
11.7.3 Hikma Exanthema Introduction
11.7.4 Hikma Revenue in Exanthema Business (2015-2020)
11.7.5 Hikma Recent Development
11.8 Nexgen Pharma
11.8.1 Nexgen Pharma Company Details
11.8.2 Nexgen Pharma Business Overview
11.8.3 Nexgen Pharma Exanthema Introduction
11.8.4 Nexgen Pharma Revenue in Exanthema Business (2015-2020)
11.8.5 Nexgen Pharma Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesTable 1. Global Exanthema Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 3. Key Players of Rubeola
Table 4. Key Players of Rubella
Table 5. Key Players of Erythema Infectiosum
Table 6. Key Players of Roseola Infantum
Table 7. Global Exanthema Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global Exanthema Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global Exanthema Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global Exanthema Market Share by Regions (2015-2020)
Table 11. Global Exanthema Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global Exanthema Market Share by Regions (2021-2026)
Table 13. Exanthema Market Market Trends
Table 14. Exanthema Market Drivers
Table 15. Exanthema Market Challenges
Table 16. Exanthema Market Restraints
Table 17. Global Exanthema Revenue by Players (2015-2020) (US$ Million)
Table 18. Global Exanthema Market Share by Players (2015-2020)
Table 19. Global Top Exanthema Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Exanthema as of 2019)
Table 20. Global Exanthema by Players Market Concentration Ratio (CR5 and HHI)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Exanthema Product Solution and Service
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Exanthema Market Size by Type (2015-2020) (US$ Million)
Table 25. Global Exanthema Market Size Share by Type (2015-2020)
Table 26. Global Exanthema Revenue Market Share by Type (2021-2026)
Table 27. Global Exanthema Market Size Share by Application (2015-2020)
Table 28. Global Exanthema Market Size by Application (2015-2020) (US$ Million)
Table 29. Global Exanthema Market Size Share by Application (2021-2026)
Table 30. North America Exanthema Market Size by Type (2015-2020) (US$ Million)
Table 31. North America Exanthema Market Share by Type (2015-2020)
Table 32. North America Exanthema Market Size by Application (2015-2020) (US$ Million)
Table 33. North America Exanthema Market Share by Application (2015-2020)
Table 34. North America Exanthema Market Size by Country (US$ Million) (2015-2020)
Table 35. North America Exanthema Market Share by Country (2015-2020)
Table 36. Europe Exanthema Market Size by Type (2015-2020) (US$ Million)
Table 37. Europe Exanthema Market Share by Type (2015-2020)
Table 38. Europe Exanthema Market Size by Application (2015-2020) (US$ Million)
Table 39. Europe Exanthema Market Share by Application (2015-2020)
Table 40. Europe Exanthema Market Size by Country (US$ Million) (2015-2020)
Table 41. Europe Exanthema Market Share by Country (2015-2020)
Table 42. China Exanthema Market Size by Type (2015-2020) (US$ Million)
Table 43. China Exanthema Market Share by Type (2015-2020)
Table 44. China Exanthema Market Size by Application (2015-2020) (US$ Million)
Table 45. China Exanthema Market Share by Application (2015-2020)
Table 46. China Exanthema Market Size by Region (US$ Million) (2015-2020)
Table 47. China Exanthema Market Share by Region (2015-2020)
Table 48. Japan Exanthema Market Size by Type (2015-2020) (US$ Million)
Table 49. Japan Exanthema Market Share by Type (2015-2020)
Table 50. Japan Exanthema Market Size by Application (2015-2020) (US$ Million)
Table 51. Japan Exanthema Market Share by Application (2015-2020)
Table 52. Japan Exanthema Market Size by Country (US$ Million) (2015-2020)
Table 53. Japan Exanthema Market Share by Country (2015-2020)
Table 54. Southeast Asia Exanthema Market Size by Type (2015-2020) (US$ Million)
Table 55. Southeast Asia Exanthema Market Share by Type (2015-2020)
Table 56. Southeast Asia Exanthema Market Size by Application (2015-2020) (US$ Million)
Table 57. Southeast Asia Exanthema Market Share by Application (2015-2020)
Table 58. Southeast Asia Exanthema Market Size by Country (US$ Million) (2015-2020)
Table 59. Southeast Asia Exanthema Market Share by Country (2015-2020)
Table 60. Manus Aktteva Biopharma Company Details
Table 61. Manus Aktteva Biopharma Business Overview
Table 62. Manus Aktteva Biopharma Product
Table 63. Manus Aktteva Biopharma Revenue in Exanthema Business (2015-2020) (US$ Million)
Table 64. Manus Aktteva Biopharma Recent Development
Table 65. Teva Pharmaceutical Industries Company Details
Table 66. Teva Pharmaceutical Industries Business Overview
Table 67. Teva Pharmaceutical Industries Product
Table 68. Teva Pharmaceutical Industries Revenue in Exanthema Business (2015-2020) (US$ Million)
Table 69. Teva Pharmaceutical Industries Recent Development
Table 70. CIRON Drugs & Pharmaceuticals Company Details
Table 71. CIRON Drugs & Pharmaceuticals Business Overview
Table 72. CIRON Drugs & Pharmaceuticals Product
Table 73. CIRON Drugs & Pharmaceuticals Revenue in Exanthema Business (2015-2020) (US$ Million)
Table 74. CIRON Drugs & Pharmaceuticals Recent Development
Table 75. Iol Chemicals and Pharmaceuticals Company Details
Table 76. Iol Chemicals and Pharmaceuticals Business Overview
Table 77. Iol Chemicals and Pharmaceuticals Product
Table 78. Iol Chemicals and Pharmaceuticals Revenue in Exanthema Business (2015-2020) (US$ Million)
Table 79. Iol Chemicals and Pharmaceuticals Recent Development
Table 80. Mikart Company Details
Table 81. Mikart Business Overview
Table 82. Mikart Product
Table 83. Mikart Revenue in Exanthema Business (2015-2020) (US$ Million)
Table 84. Mikart Recent Development
Table 85. Ranbaxy Laboratories Company Details
Table 86. Ranbaxy Laboratories Business Overview
Table 87. Ranbaxy Laboratories Product
Table 88. Ranbaxy Laboratories Revenue in Exanthema Business (2015-2020) (US$ Million)
Table 89. Ranbaxy Laboratories Recent Development
Table 90. Hikma Company Details
Table 91. Hikma Business Overview
Table 92. Hikma Product
Table 93. Hikma Revenue in Exanthema Business (2015-2020) (US$ Million)
Table 94. Hikma Recent Development
Table 95. Nexgen Pharma Business Overview
Table 96. Nexgen Pharma Product
Table 97. Nexgen Pharma Company Details
Table 98. Nexgen Pharma Revenue in Exanthema Business (2015-2020) (US$ Million)
Table 99. Nexgen Pharma Recent Development
Table 100. Research Programs/Design for This Report
Table 101. Key Data Information from Secondary Sources
Table 102. Key Data Information from Primary Sources
List of FiguresFigure 1. Global Exanthema Market Share by Type: 2020 VS 2026
Figure 2. Rubeola Features
Figure 3. Rubella Features
Figure 4. Erythema Infectiosum Features
Figure 5. Roseola Infantum Features
Figure 6. Global Exanthema Market Share by Application: 2020 VS 2026
Figure 7. Hospitals and Clinics Case Studies
Figure 8. Others Case Studies
Figure 9. Exanthema Report Years Considered
Figure 10. Global Exanthema Market Size (US$ Million), YoY Growth 2015-2026
Figure 11. Global Exanthema Market Share by Regions: 2020 VS 2026
Figure 12. Global Exanthema Market Share by Regions (2021-2026)
Figure 13. Global Exanthema Market Share by Players in 2019
Figure 14. Global Top Exanthema Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Exanthema as of 2019
Figure 15. The Top 10 and 5 Players Market Share by Exanthema Revenue in 2019
Figure 16. North America Exanthema Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 17. United States Exanthema Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 18. Canada Exanthema Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 19. Europe Exanthema Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 20. Germany Exanthema Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 21. France Exanthema Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 22. U.K. Exanthema Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 23. Italy Exanthema Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 24. Russia Exanthema Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 25. Nordic Exanthema Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 26. Rest of Europe Exanthema Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 27. Asia-Pacific Exanthema Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 28. China Exanthema Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 29. Japan Exanthema Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 30. South Korea Exanthema Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 31. Southeast Asia Exanthema Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 32. India Exanthema Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 33. Australia Exanthema Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 34. Rest of Asia-Pacific Exanthema Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 35. Latin America Exanthema Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 36. Mexico Exanthema Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 37. Brazil Exanthema Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 38. Middle East & Africa Exanthema Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 39. Turkey Exanthema Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 40. Saudi Arabia Exanthema Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 41. UAE Exanthema Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 42. Rest of Middle East & Africa Exanthema Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 43. Manus Aktteva Biopharma Revenue Growth Rate in Exanthema Business (2015-2020)
Figure 44. Teva Pharmaceutical Industries Revenue Growth Rate in Exanthema Business (2015-2020)
Figure 45. CIRON Drugs & Pharmaceuticals Revenue Growth Rate in Exanthema Business (2015-2020)
Figure 46. Iol Chemicals and Pharmaceuticals Revenue Growth Rate in Exanthema Business (2015-2020)
Figure 47. Mikart Revenue Growth Rate in Exanthema Business (2015-2020)
Figure 48. Ranbaxy Laboratories Revenue Growth Rate in Exanthema Business (2015-2020)
Figure 49. Hikma Revenue Growth Rate in Exanthema Business (2015-2020)
Figure 50. Nexgen Pharma Revenue Growth Rate in Exanthema Business (2015-2020)
Figure 51. Bottom-up and Top-down Approaches for This Report
Figure 52. Data Triangulation
Figure 53. Key Executives Interviewed